• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-19A
Device Problem Biocompatibility (2886)
Patient Problems Aortic Regurgitation (1716); Mitral Regurgitation (1964); Tricuspid Regurgitation (2112)
Event Date 08/02/2019
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The investigation results will be provided in a subsequent submission.
 
Event Description
In 2016, an double valve replacement procedure and a tricuspid annuloplasty were conducted.On (b)(6) 2019, the patient was referred to the hospital for heart failure.The patient was noted to have aortic regurgitation, mitral regurgitation and tricuspid regurgitation.On (b)(6) 2019, a re-do dvr and tap were performed and both valves were replaced with mechanical valves (serial number unknown).The physician reported endocarditis and pannus on the right coronary cusp.Since the procedure was performed at another hospital, the physician is unable to determine if the reported event was due to the initial procedure or patient condition.Additional information has been requested.
 
Manufacturer Narrative
Explant was reported due to aortic regurgitation.The investigation found that all three leaflets were fibrotically thickened.No vegetations, thrombi, calcifications or acute inflammation were present.Basophilic foreign material, consistent with surgical material and presumed to be procedure related, were present on the surface of leaflet 3.The cause of the reported event could not be conclusively determined.
 
Event Description
In 2016, an double valve replacement procedure and a tricuspid annuloplasty were conducted.On (b)(6) 2019, the patient was referred to the hospital for heart failure.The patient was noted to have aortic regurgitation, mitral regurgitation and tricuspid regurgitation.On (b)(6) 2019, a re-do dvr and tap were performed and both valves were replaced with mechanical valves (serial number unknown).The physician reported endocarditis and pannus on the right coronary cusp.Since the procedure was performed at another hospital, the physician is unable to determine if the reported event was due to the initial procedure or patient condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (CVD)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS  1897-4050
MDR Report Key8945598
MDR Text Key155986461
Report Number3008452825-2019-00436
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup
Report Date 10/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTF-19A
Device Catalogue NumberTF-19A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/26/2019
Was the Report Sent to FDA? No
Date Manufacturer Received09/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Weight40
-
-